Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

Characteristics of Breast Cancer Patients with Central Nervous System Metastases: A Single-Center Experience

(2015) Hakan Harputluoglu et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience

(2010) S Sutherland et al.   BRITISH JOURNAL OF CANCER

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

(2009) N. U. Lin et al.   CLINICAL CANCER RESEARCH

Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy

(2009) Hye-Suk Han et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy

(2008) Bhumsuk Keam et al.   BREAST CANCER RESEARCH AND TREATMENT

Brain metastases: current management and new developments

(2008) Riccardo Soffietti et al.   CURRENT OPINION IN ONCOLOGY